National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 99,646 cases where Vaccine targets Shingles (VARZOS) and Submission Date on/before '2018-05-31'

Government Disclaimer on use of this data



Case Details

This is page 3 out of 9,965

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12   next


VAERS ID: 262885 (history)  
Form: Version 1.0  
Age: 71.0  
Sex: Female  
Location: Texas  
Vaccinated:2006-08-27
Onset:2006-08-31
   Days after vaccination:4
Submitted: 2006-09-08
   Days after onset:8
Entered: 2006-09-12
   Days after submission:4
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 UN / SC

Administered by: Private       Purchased by: Private
Symptoms: Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Hyperlipidaemia
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0609USA00425

Write-up: Information has been received from a physician concerning a 71 year old female who on 8/27/06 was vaccinated with a 0.65 ml dose of varicella zoster virus vaccine live. On 8/31/06 the pt experienced a shingles like rash on her mid torso. The physician treated her with the anti viral Famciclovir (Famvir). There was no product quality complaint involved. The physician considered the pts shingles like rash to be an other important medical event (OMIC). Additional information has been requested.


VAERS ID: 263065 (history)  
Form: Version 1.0  
Age: 61.0  
Sex: Female  
Location: Georgia  
Vaccinated:2006-09-11
Onset:2006-09-12
   Days after vaccination:1
Submitted: 2006-09-14
   Days after onset:2
Entered: 2006-09-15
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 LA / SC

Administered by: Public       Purchased by: Private
Symptoms: Headache, Injection site erythema, Injection site induration, Injection site oedema, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Allergies to Emysin, Neurotin, Codeine, Cymbalta.
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type:

Write-up: Left arm at injection site erythema, swelling same hardness. Client states reaction started 9/12/06. She also states HA and temperature.


VAERS ID: 263188 (history)  
Form: Version 1.0  
Age: 57.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2006-08-05
Onset:2006-08-06
   Days after vaccination:1
Submitted: 2006-09-13
   Days after onset:38
Entered: 2006-09-19
   Days after submission:6
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / UNK LA / SC

Administered by: Private       Purchased by: Private
Symptoms: Injection site induration
SMQs:, Extravasation events (injections, infusions and implants) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Induration 7x9 cm lasting 10 days.


VAERS ID: 263317 (history)  
Form: Version 1.0  
Age: 71.0  
Sex: Male  
Location: Texas  
Vaccinated:2006-08-28
Onset:2006-08-28
   Days after vaccination:0
Submitted: 2006-09-01
   Days after onset:4
Entered: 2006-09-20
   Days after submission:19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0621F / 1 LA / SC

Administered by: Private       Purchased by: Private
Symptoms: Blister, Injection site erythema, Injection site pain, Injection site reaction, Injection site warmth, Pruritus
SMQs:, Severe cutaneous adverse reactions (broad), Anaphylactic reaction (broad), Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type:

Write-up: Local reaction at injection site: redness pain, blisters, warmth, itching. No treatment.


VAERS ID: 263477 (history)  
Form: Version 1.0  
Age: 75.0  
Sex: Female  
Location: California  
Vaccinated:2006-09-05
Onset:0000-00-00
Submitted: 2006-09-22
Entered: 2006-09-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0722F / 1 LA / SC

Administered by: Private       Purchased by: Private
Symptoms: Dermatitis bullous, Skin ulcer
SMQs:, Severe cutaneous adverse reactions (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: DM, HTN, Hyperlipidemia
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type:

Write-up: Started with one lesson on the left temple, next day developed more in axillae and also under the breast. On exam the lesions look like varicella.


VAERS ID: 263489 (history)  
Form: Version 1.0  
Age: 71.0  
Sex: Female  
Location: South Carolina  
Vaccinated:2006-09-05
Onset:2006-09-05
   Days after vaccination:0
Submitted: 2006-11-20
   Days after onset:76
Entered: 2006-09-25
   Days after submission:56
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 UN / -

Administered by: Private       Purchased by: Private
Symptoms: Medication error, Purpura, Rash pruritic
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Fosamax, Lipitor, ASA, Mobic, Calcium, Flecainide, OxyContin, Vitamin E
Current Illness: NONE
Preexisting Conditions: Melanoma 1982, hyperlipidemia, osteoporosis, previous PAT.
Allergies:
Diagnostic Lab Data: Platelets 236, WBC 7.4, HBG 11.8
CDC Split Type:

Write-up: Pt presented 2 days following Zostavax administration with pruritic, purpuric rash, rash extended after tx with Benadryl. 9/10/06 placed on Prednisone at which time rash resolved. Extension was generalized to body. CBC 6/11/06, Platelets 236, HCT 34.4. HBG 11.8.


VAERS ID: 263490 (history)  
Form: Version 1.0  
Age: 73.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2006-08-22
Onset:2006-08-30
   Days after vaccination:8
Submitted: 2006-09-25
   Days after onset:26
Entered: 2006-09-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 LA / -

Administered by: Private       Purchased by: Private
Symptoms: Herpes zoster, Viral infection
SMQs:, Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Lisinopril, Glyburide, Aspirin, Crestor, Niaspan, Multivitamin, Omega 3 fish oil, Atenolol, Nifedical XL, Lumigan.
Current Illness: NONE
Preexisting Conditions: Hypertension, Diabetes, Cholesterol, Ocular pressure control. Allergy to IV contrast dye.
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Received a Zostavax shot on 8/22/06, shingles rash appeared on 8/30/06. 10/26/06 Requested by FDA to contact reporter to clarify which vaccine given. 10/27/06 T/C to reporter/provider to request missing info. Letter faxed to PCP to request medical records/ss 10/27/06 Received medical records from PCP which reveal that patient was new patient at this MD & he received Zotavax per the vax records. However, the MD note indicates a different lot number. T/C to PCP to confirm which vax lot number is correct as record is unclear. T/C to manufacturer to inquire what lot number for which vax. Stated lot number on report is for Gardisil & that lot number in MD records is correct for Zostavax. Notified FDA of same./ss


VAERS ID: 263512 (history)  
Form: Version 1.0  
Age: 65.0  
Sex: Female  
Location: Maryland  
Vaccinated:2006-09-22
Onset:2006-09-23
   Days after vaccination:1
Submitted: 2006-12-20
   Days after onset:88
Entered: 2006-09-25
   Days after submission:86
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / UN
PPV: PNEUMO (PNEUMOVAX) / MERCK & CO. INC. - / UNK UN / UN
TTOX: TETANUS TOXOID (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / UN
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 RA / SC

Administered by: Other       Purchased by: Other
Symptoms: Influenza like illness
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No concurrent medication ALLEGRA; ADVAIR; SINGULAIR
Current Illness: sulfa allergy Asthma; Penicillin allergy; Drug hypersensitivity; Seasonal allergy
Preexisting Conditions: There were no concomitant medications or pertinent medical history. The subject''s concurrent medical conditions were not supported.
Allergies:
Diagnostic Lab Data: No lab diagnostic studies were performed. Serum varicella zoster, 10/05/06, 4.24, IgG antibody test, high positive; Serum varicella zoster, 10/05/06, <0.90, IgN antibody rest, negative
CDC Split Type: A0610558A

Write-up: This case was reported by a pharmacist and described a 63-year-old female subject who developed severe flu symptoms after receiving an influenza vaccination (other manufacturer) . There were no concomitant medications or pertinent medical history. The subject''s concurrent medical conditions were not reported. The subject had a sulfa allergy. On an unspecified date several years ago, the subject received influenza vaccine (unknown manufacturer: dose number and lot number not provided). On an unspecified date, the subject developed severe flu symptoms after receiving the influenza vaccination. No other symptoms were reported. No other information was available. This is in follow-up to report (s) previously submitted on 10/16/2006. Information has been received from a physician and a 65-year-old female who is a physician with asthma, allergies (ragweed) and penicillin an aspirin allergies, who on 22-SEP-2006 at 10:30 am was vaccinated subcutaneously in the right arm with a first dose 0.65 ml dose of ZOSTAVAX vaccine (Merck). Concomitant vaccination included: a dose of pneumococcal 23v ploysaccharide vaccine (MSD), a dose of inlfuenza virus vaccine (unspecified) (given on the same arm about 3 inches away from the site of varicella-zoster virus vaccine live (Merck) administration) and a dose of tetanus toxoid vaccine (manufacturer unknown). Other concomitant medications included: ADVAIR, SINGULAIR and ALLEGRA. On 23-SEP-2006 the patient expereinced a severe localized reaction on her right arm including erythema, pain/tenderness, swelling, pruritus and warmth. The patient did not experience any systemic reations, no fever, no sore throat and no joint pain. It was reported that the reaction gradually subsided after 6 days and significantly reduced after 10 days. On 05-OCT-2006, the patient was seen by the allergist, she still had a mild macular eythema, but no other skin lesions were identified. The patient was also wondering whether she should receive her additional allergy immunotherapy which she is getting about once every 4 weeks. She was also treated in the allergist office for asthma, aspirin and penicillin allergy. The physician discussed the potential etiologies for her raction to varicella-zoste virus vaccine live (Merck). The time sequence may resemble either type-3 or type-4 hypersensitivity. In addition, patch testing for varicella-zoster virus vaccine live (Merck) may also be beneficial which potentially can help us to identify whether she has any T-cell mediated hypersensitivity reaction. There is always a possibility the reaction could be directed to the preservatives. Ingredients of the vaccination have to be examined to see whether additional patch testing can be performed. The physician recommended that she get IgG and IgM antibody titers for VEV. The results of these tests were varicella-zoster Ab, IgM = < 0.90 (negative) and varicellla-zoster V Ab, IgG = 4.24 (positive). The physician noted that the patient could continue her current prescribed allergy and asthma medication and continue to receive her immunothereapy as planned. No product quality complaint was involved. No additional information has been requested.


VAERS ID: 263519 (history)  
Form: Version 1.0  
Age: 65.0  
Sex: Female  
Location: Maryland  
Vaccinated:2006-09-22
Onset:2006-09-23
   Days after vaccination:1
Submitted: 2006-09-25
   Days after onset:2
Entered: 2006-09-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / IM
PPV: PNEUMO (PNEUMOVAX) / MERCK & CO. INC. - / UNK - / IM
TD: TD ADSORBED (DITANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / IM
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK - / SC

Administered by: Unknown       Purchased by: Unknown
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site pain, Injection site swelling, Injection site warmth, Pruritus, Sleep disorder
SMQs:, Anaphylactic reaction (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: none
Preexisting Conditions: Allergic to Penicillin and Aspirin Mild Asthma. Takes Advair 100
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: 24 hours after injection of SHINGLES VACCINE developed local VERY SEVERE SWELLING, REDNESS, PRURITUS, PAINFUL, HOT. 3/4 of the arm, encircling it. Can not sleep because of itching and pain. No systemic symptoms. The patient is a Pediatrician well versed in vaccine reactions. The patient takes Advair 100 for mild asthma. Received a flu shot in the same arm, same date, different area of the arm. At 72 hours the reaction persists.


VAERS ID: 263741 (history)  
Form: Version 1.0  
Age: 84.0  
Sex: Male  
Location: New York  
Vaccinated:2006-09-08
Onset:2006-09-09
   Days after vaccination:1
Submitted: 2006-09-21
   Days after onset:12
Entered: 2006-09-29
   Days after submission:8
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0621F / 1 LA / SC

Administered by: Private       Purchased by: Private
Symptoms: Herpes zoster, Injection site reaction, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cartia; Digoxin; Aricept
Current Illness: NONE
Preexisting Conditions: COPD
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: H Zoster outbreak L Gluteus 24 hours after administration. This is in follow-up to report (s) previously submitted on 10/2/2006; 10/5/2006. Information has been received from a physician concerning a male patient who on 08-SEP-2006 was vaccinated with a dose of varicella-zoster virus vaccine live (Oka/Merck). On 09-SEP-2006, the patient was hospitalized with a rash. The patient was diagnosed with a zoster infection. No outcome was reported. No product quality complaint was involved. Additional information has been received from a physician on 09-0CT-2006. He reported that the patient was an 84-year-old male with Early Senile Dementia, steroid dependent chronic obstuctive pulmonary disease (COPD), coronary artery disease (CAD), hypertension (HTN), hyperlipidemia and osteoporosis/osteoarthritis, who on 08-SEP-2006 was vaccinated in the left upper extremity with a dose of varicella-zoster virus vaccine live (Oka/Merck) (lot# 652925/0621F). Concomitant therapy included: predisone 5mg daily, potassium supplements, digoxin, antibiotics prn, simvastatin (MSD), tiotropium bromide (SPIRIVA), clopidogrel bisulfate (PLAVIX), furosemide (LASIX), formoterol fumarate (FORADIL), aspirin (CARTIA), donepesil hydrochloride (ARICEPT) and ramipril (ALTACE). On 09-SEP-2006 the patient was seen in the emergency room and diagnosed with Herpes Zoster; however, the patient was not admitted (as previously reported). The physician reported that the patient was in a lot of pain and was treated with hydrocodone which made dementia worse. The patient was treated with valacyclovir hydrochloride (VALTREX). 1gm, TID for 7 days, for herpes zoster. The physician saw the patient a few days alter and hisrash looked like a "typical zoster rash". The rash was only on his left buttock. The physician felt that the patient''s experiences were serious. He was concerned about the patient and believed that his medical condition was "extremely brittle" due to his COPD. The physician reported that the patient recovered on an unspecified date. The physician considered the herpes zoster to be an other important medical event. Additional information is expected.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=3&VAX=VARZOS&VAXTYPES=Shingles&SUB_YEAR_HIGH=2018&SUB_MONTH_HIGH=05


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166